Comparative chemogenetic profiling of Hedgehog pathway inhibitors reveals class-specific genetic modifiers
Year: 2026
Type: preprint
Abstract: Chemogenetic profiling is a powerful method to dissect compound-gene interactions and to reveal a compound's mechanism of action and possible resistance mechanisms. Here, we extended the use of chemogenetic profiling beyond cytotoxic compounds to classify non-toxic inhibitors of the Hedgehog signaling pathway. We performed Hedgehog pathway-focused genetic screens in NIH/3T3 mouse fibroblasts using two chemically distinct inhibitors each of Smoothened (SMO) and BET bromodomain proteins. The resulting chemogenetic profiles revealed class-specific modifiers, with loss of Mosmo conferring resistance to SMO inhibitors, and loss of Paxip1 conferring resistance to BET bromodomain inhibitors. Beyond these compound-specific effects, we show how loss of Nf2, Paxip1, or Mosmo differentially impacts Hedgehog pathway transduction upstream, at the level of the cilium, and/or downstream, at the level of transcription. Together, the Mosmo- and Paxip1-knockout lines provide new tools for epistasis mapping, and the profiling strategy a route to mechanism-of-action studies for inhibitors of ciliary signaling.
Authors: Quentin T.L. Pasquer(Conceptualization, Formal analysis, Investigation, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review & editing), Charlotte Rossion(Investigation, Methodology, Supervision, Writing – review & editing), Hao Li(Investigation, Writing – review & editing), Rocaya C. Gross(Investigation, Writing – review & editing), Sascha Hoogendoorn(Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing)
Institution: University of Geneva
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: Novartis Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Novartis Stiftung für Medizinisch-Biologische Forschung, Université de Genève, National Center of Competence in Research Chemical Biology, National Institutes of Health, Institute of Genetics and Genomics of Geneva
OpenAlex ID: W7235102904
